Dual GCGR/GLP-1R agonist with optimized receptor selectivity. ≥98% purity, 10 mg lyophilized. For laboratory research only.
$85.00
This product has been added to 0 people's carts.
Share:
We dispatch your product in 24-48 hours.
We package our products to keep them safe and temperature controlled for high-purity.
We encrypt all payment information so that your card is safe.
Featuring optimized receptor selectivity ratios between GLP-1R and GCGR, Survodutide has been investigated in Phase II and III clinical trials for metabolic conditions. Its unique pharmacological profile enables researchers to study the synergistic effects of coordinated incretin and glucagon receptor engagement on energy expenditure and hepatic lipid metabolism.
You can call anytime from 9 am to 5 pm PST.
You can email us anytime.
Reviews
There are no reviews yet.